Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

VRT

Vertiv's Q1 2026 Revenue Jumps 30%

Vertiv reported first-quarter 2026 net sales of $2.65 billion, up 30% from $2.036 billion a year earlier, as organic growth, acquisitions and currency all contributed to the increase. Organic sales rose 23%, acquisitions added 4%, and foreign exchange added 3%.

Operating profit climbed to $440 million from $291 million in the first quarter of 2025, an increase of 51%. Adjusted operating profit rose 64% to $551 million from $337 million, lifting adjusted operating margin to 20.8% from 16.5%, a gain of 430 basis points.

Earnings per share also improved sharply. Diluted EPS increased 136% year over year, while adjusted diluted EPS rose 83%.

Cash generation strengthened as well. Net cash from operating activities reached $767 million, up 153% from the prior-year quarter, and adjusted free cash flow increased 147% to $653 million. Vertiv ended the quarter with net leverage of about 0.2x and liquidity of $5.0 billion.

By region, the Americas led growth, with organic sales up 44% on stronger data center demand.

For full-year 2026, Vertiv now expects net sales of $13.5 billion to $14.0 billion, implying organic sales growth of 29% to 31% versus 2025. It raised its adjusted diluted EPS outlook to $6.30 to $6.40, and its diluted EPS guidance to $5.60 to $5.70. At the midpoint, that represents increases of 51% and 66%, respectively, versus full-year 2025.

For the second quarter, Vertiv guided to net sales of $3.25 billion to $3.45 billion, adjusted operating profit of $690 million to $730 million, and adjusted diluted EPS of $1.37 to $1.43. As a result of these announcements, the company's shares have moved -8.6% on the market, and are now trading at a price of $252.40. For the full picture, make sure to review Vertiv's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS